Penn State University College of Medicine

Preamble CEO selected for CEOcircle Program's new cohort

Retrieved on: 
Wednesday, October 11, 2023

PITTSBURGH, Oct. 11, 2023 /PRNewswire/ -- Jeremy McHugh, CEO and co-founder of Preamble, Inc., has been named a member of the new cohort for CEOcircle, a program launched in 2021 by Bunker Labs and JPMorgan Chase Commercial Banking. The year-long program builds a brain-trust of peers dedicated to helping companies scale and grow through education, connections, and networking.  

Key Points: 
  • PITTSBURGH, Oct. 11, 2023 /PRNewswire/ -- Jeremy McHugh, CEO and co-founder of Preamble, Inc. , has been named a member of the new cohort for CEOcircle , a program launched in 2021 by Bunker Labs and JPMorgan Chase Commercial Banking.
  • Preamble is a Pittsburgh-based technology startup pioneering SaaS-based safety and security for generative AI systems.
  • It is the only AI safety-focused business and Pennsylvania-based company in the 2023 cohort.
  • Preamble also recently announced it has joined NVIDIA Inception , a program that nurtures startups revolutionizing industries with technological advancements.

Mount Sinai Announces New System Chief of Genomic Medicine

Retrieved on: 
Tuesday, September 26, 2023

NEW YORK, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Michael F. Murray, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, has been named the new System Chief of the Division of Genomic Medicine and the Clinical Director of the Institute for Genomic Health at Mount Sinai. He will lead its efforts to harness the power of genomic discovery to develop new ways to prevent and treat diseases, including cancers, heart problems, and genetic disorders.

Key Points: 
  • Michael F. Murray, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, has been named the new System Chief of the Division of Genomic Medicine and the Clinical Director of the Institute for Genomic Health at Mount Sinai.
  • NEW YORK, Sept. 26, 2023 /PRNewswire-PRWeb/ -- Michael F. Murray, MD, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, has been named the new System Chief of the Division of Genomic Medicine and the Clinical Director of the Institute for Genomic Health at Mount Sinai.
  • Before joining the Mount Sinai Health System, he led cutting-edge efforts to integrate genomic medicine into clinical care delivery at Harvard Medical School, Geisinger Community Medical Center, and Yale New Haven Health System.
  • "With the investment that the Mount Sinai Health System has made in genetics and genomics technology in the clinical and research arenas, we are making an impact upon the care we provide to patients in a significant way," said Monica Kraft, MD, the Murray M. Rosenberg Professor of Medicine and System Chair of the Department of Medicine at Mount Sinai Health System and Icahn Mount Sinai.

American Canadian School of Medicine Receives Another Accreditation

Retrieved on: 
Thursday, July 20, 2023

PORTSMOUTH, Dominica, July 20, 2023 /PRNewswire-PRWeb/ -- The American Canadian School of Medicine (ACSOM) is proud to announce that it has successfully completed the initial accreditation process by the Accreditation Commission on Colleges of Medicine (ACCM), a globally recognized organization. With the accreditation obtained last month by Independent Agency for Accreditation and Rating (IAAR), ACSOM will now begin its inaugural class with two accreditations that are recognized by the World Federation of Medical Education (WFME). With the dual WFME recognition, ACSOM graduates are eligible to receive an Educational Commission for Foreign Medical Graduates (ECFMG) certificate, a requirement to pursue residency training in North America.

Key Points: 
  • PORTSMOUTH, Dominica, July 20, 2023 /PRNewswire-PRWeb/ -- The American Canadian School of Medicine (ACSOM) is proud to announce that it has successfully completed the initial accreditation process by the Accreditation Commission on Colleges of Medicine (ACCM), a globally recognized organization.
  • During the accreditation process, ACCM reported that ACSOM has the infrastructure to successfully operate a medical school.
  • The American Canadian School of Medicine (ACSOM) is a non-profit international medical school based in Dominica.
  • ACSOM is accredited by the Independent Agency for Accreditation and Rating (IAAR) and the Accreditation Commission on Colleges of Medicine (ACCM) and recognized by the World Federation of Medical Education (WFME).

American Canadian School of Medicine Achieves Accreditation Exceptional Facilities, Innovative Curriculum and An Esteemed Faculty Distinguishes the New Medical School

Retrieved on: 
Monday, June 26, 2023

PORTSMOUTH, Dominica, June 26, 2023 /PRNewswire-PRWeb/ -- The American Canadian School of Medicine (ACSOM) is delighted to announce that it will begin its inaugural class with accreditation by the Independent Agency on Accreditation and Rating (IAAR), which is recognized by the World Federation of Medical Education (WFME). Achieving IAAR accreditation included an extensive inspection of the campus and teaching facilities, intensive review of the curriculum and a series of interviews with faculty and school leadership.

Key Points: 
  • Achieving IAAR accreditation included an extensive inspection of the campus and teaching facilities, intensive review of the curriculum and a series of interviews with faculty and school leadership.
  • "American Canadian School of Medicine is truly forward-thinking in its approach to medical education.
  • The American Canadian School of Medicine (ACSOM) is the first nonprofit international medical school in the Caribbean, with its campus based in Dominica.
  • For more information about the American Canadian School of Medicine, please visit http://www.acsom.edu.dm

Cellarity Appoints Dr. Gregory J. Moore to Board of Directors

Retrieved on: 
Tuesday, June 6, 2023

Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the appointment of Gregory J. Moore, M.D., Ph.D., to the Company’s Board of Directors.

Key Points: 
  • Cellarity , a life sciences company founded by Flagship Pioneering to transform the way medicines are created, announced today the appointment of Gregory J. Moore, M.D., Ph.D., to the Company’s Board of Directors.
  • “Greg is an industry leader, driving technology and life sciences innovation at the intersection of medical and large-scale computation,” said Stephen Berenson, Chairman of Cellarity’s Board of Directors and Managing Partner at Flagship Pioneering.
  • Dr. Moore is board certified in Diagnostic Radiology, Neuroradiology, and Clinical Informatics.
  • He currently serves as an independent director on the boards of DaVita (NYSE:DVA) and Olink Holding AB (NASDAQ:OLK).

Sana Primary Care Appoints Virtual Primary Care Pioneer Dr. Jay Parkinson as Chief Medical Officer

Retrieved on: 
Wednesday, May 17, 2023

Sana , the leading provider of health benefits to small businesses at affordable prices, today announced that Dr. Jay Parkinson has joined the company as Chief Medical Officer of Sana Primary Care.

Key Points: 
  • Sana , the leading provider of health benefits to small businesses at affordable prices, today announced that Dr. Jay Parkinson has joined the company as Chief Medical Officer of Sana Primary Care.
  • View the full release here: https://www.businesswire.com/news/home/20230517005027/en/
    Dr. Jay Parkinson, Chief Medical Officer at Sana Primary Care.
  • (Photo: Business Wire)
    Parkinson is a healthcare entrepreneur and physician who has co-founded multiple healthcare startups, including Sherpaa, a pioneer of the virtual primary care model.
  • “Joining the team at Sana Primary Care is an exciting next phase for me in the healthcare industry,” Parkinson said.

Research Study on Comfort of the New FLUME Catheter to Begin Recruitment

Retrieved on: 
Friday, April 28, 2023

The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced the launch of a study to gather real-world data on patient experiences with the new FLUME catheter.

Key Points: 
  • The Flume Catheter Company Ltd. (TFCC), a medical device company dedicated to developing an improved alternative to the Foley indwelling urinary catheter, announced the launch of a study to gather real-world data on patient experiences with the new FLUME catheter.
  • The FLUME catheter is distinguished by an alternative balloon configuration, designed to envelop the tip of the catheter upon inflation and, thereby, allow the emptying bladder to come into contact with the compliant balloon rather than a rigid catheter tip.
  • , FLUME Catheter Comfort Study Principal Investigator, and associate professor of Surgery in the Division of Urology at Duke University School of Medicine .
  • This could be game-changer for these patients.”
    The new study will help researchers learn more about whether the FLUME catheter may improve patients’ perceptions around comfort and quality of life.

AWARE RECOVERY CARE ANNOUNCES NEW CHIEF MEDICAL OFFICER

Retrieved on: 
Tuesday, April 11, 2023

WALLINGFORD, Conn., April 11, 2023 /PRNewswire/ -- Aware Recovery Care, a pioneer in the in-home mental health and substance use disorder treatment industry, announced today that it has appointed Lauren H. Grawert, MD, as the company's new Chief Medical Officer (CMO).

Key Points: 
  • WALLINGFORD, Conn., April 11, 2023 /PRNewswire/ -- Aware Recovery Care, a pioneer in the in-home mental health and substance use disorder treatment industry, announced today that it has appointed Lauren H. Grawert, MD, as the company's new Chief Medical Officer (CMO).
  • She received her medical and psychiatric residency training, and addiction fellowship completion, at Medical University of South Carolina.
  • "Dr. Grawert brings broad and deep experience as both a medical doctor and an accomplished leader in the field, and I'm delighted to have her join the Aware Recovery Care team," said Dr. Holzer.
  • I look forward to helping Aware uphold best-in-class addiction care for the patients that need us."

Live Remote Cardiac MRI Exam to Showcase Vista.ai's Automated and Virtual Scan Capabilities at ACC.23/WCC

Retrieved on: 
Friday, March 3, 2023

NEW ORLEANS, March 3, 2023 /PRNewswire/ -- Vista.ai, a pioneer and leader in automated MRI solutions, today announced that Dr. Michael Salerno, Chief, Cardiovascular Imaging at Stanford Health Care, will conduct a live remote cardiac MRI (CMR) scan using the company's One Click MRI™ software at the American College of Cardiology's 72nd Annual Scientific Session Together With World Heart Federation's World Congress of Cardiology (ACC.23/WCC). Dr. Salerno will scan a patient at Stanford Health in Palo Alto, Calif., virtually from the ACC.23/WCC Future Hub stage in New Orleans at 11 a.m. CST on March 5, 2023.

Key Points: 
  • One Click MRI's benefits include simple, streamlined workflows and improved image consistency, so any MRI technologist can complete a cardiac scan in a regular mixed-use MRI time slot.
  • "With Vista.ai's One Click MRI, CMRs are much more efficient and streamlined, which greatly improves our ability to scan patients who need them.
  • In addition to simplifying clinical workflows and shortening scan times, One Click MRI allows technologists, wherever they are available, to conduct a patient scan at a remote hospital, so long as the facility has an MRI scanner.
  • While One Click MRI is initially focused on automating and simplifying a CMR exam, Vista.ai recently announced planned expansion beyond the heart to other anatomies and clinical areas.

PENN STATE THON™ RAISES $15,006,132.46 FOR CHILDHOOD CANCER AND BREAKS ALL-TIME ANNUAL FUNDRAISING RECORD

Retrieved on: 
Sunday, February 19, 2023

UNIVERSITY PARK, Pa., Feb. 19, 2023 /PRNewswire/ -- Today, Penn State THON, the world's largest student-run philanthropy that delivers year-round financial and emotional aid to families affected by childhood cancer, announced that it raised an all-time annual high of $15,006,132.46 following the organization's annual 46-hour no sleeping or sitting dance marathon. All proceeds from THON's fundraising efforts benefit its sole beneficiary Four Diamonds, a national nonprofit gift fund that covers 100% of all medical expenses for families with childhood cancer at Penn State Health Children's Hospital, while also supporting an extensive cancer research program at Penn State College of Medicine.

Key Points: 
  • All proceeds from THON's fundraising efforts benefit its sole beneficiary Four Diamonds, a national nonprofit gift fund that covers 100% of all medical expenses for families with childhood cancer at Penn State Health Children's Hospital, while also supporting an extensive cancer research program at Penn State College of Medicine.
  • Founded by Charles and Irma Millard following the passing of their son Christopher to pediatric cancer, Four Diamonds and THON have been partners in the fight against childhood cancer since 1977.
  • Over the last 51 years, THON and Four Diamonds have helped over 4,800 families experiencing childhood cancer by covering all medical expenses, including comprehensive specialty care services at Penn State Health Children's Hospital.
  • They've helped create and develop a multifaceted cancer research program in collaboration with Penn State Milton S. Hershey Medical Center and Penn State College of Medicine.